Delic Corp

Delic to Acquire Ketamine Wellness Centers Inc, Becoming Largest Psychedelic Wellness Chain in United States

Quick Take: Delic has announced a merger with Arizona-based ketamine infusion clinic company KWC. KWC operates 10 clinics across multiple states, cementing Delic’s position as the largest ketamine health provider in the country. Delic Holdings Corp (CSE: DELC) (OTCQB: DELCF), the leading psychedelic wellness platform today announced it has entered into a binding merger agreement […]

Enveric Biosciences Announces Closing of MagicMed Industries Acquisition

Quick Take: MagicMed, a privately-held biotechnology company with a focus on DMT and psilocybin, has been acquired by Enviric Enveric Biosciences (NASDAQ: ENVB), a patient-centric biotechnology company developing novel cannabinoid medicines to improve quality of life for cancer patients, today announced the closing of its acquisition of MagicMed Industries Inc. (“MagicMed”), a privately-held biotechnology company focused on […]

COMPASS Pathways

COMPASS Pathways acquires IP portfolio of novel psychedelic compounds and prodrugs

COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, announced that it has acquired an intellectual property (IP) portfolio including patent applications covering a variety of psychedelic and empathogenic substances. The IP was developed together with inventor Matthias Grill PhD, founder and CEO […]

Awakn life sciences

Awakn Life Sciences to Acquire Leading Ketamine-assisted Psychotherapy Clinic in Norway

Quick Take: Awakn will acquire a 100% interest in Axon, a ketamine-assisted psychotherapy clinic in Norway. Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) a biotechnology company developing and delivering psychedelic medicine to treat addiction, is pleased to announce that it has signed a binding share exchange agreement to acquire a 100% interest […]